rivercyte

The future of cell analysis. Stay tuned.

[rivercyte @rivercyte]

We are super proud to be the finalists of phase 1 of the Bavarian startup competition Businessplan Wettbewerb Nordbayern 2025!

Come talk to us at #StartupDemoNight on 11th March in Nurnberg & check out our #Naiad blood cell analysis system!

#startups #nordbayern @BayStartUp

[rivercyte @rivercyte]

Yesterday at the #StartupDemoNight we were announced as a winning team of Phase 1 of the Bavarian Business Plan Competition @BayStartUp🤩fantastic event!

[rivercyte @rivercyte]

@BayStartUp Check out all the finalists and register for the event here https://t.co/pR1V5YZI4j

[rivercyte @rivercyte]

@BayStartUp Check out all the finalists and register for the event here https://t.co/pR1V5YZI4j

[rivercyte @rivercyte]

We are super proud to be the finalists of phase 1 of the Bavarian startup competition Businessplan Wettbewerb Nordbayern 2025!

Come talk to us at #StartupDemoNight on 11th March in Nurnberg & check out our #Naiad blood cell analysis system!

#startups #nordbayern @BayStartUp

[Martin Kräter @KraterMartin]

Happy users 👇 so excited to see the coming discoveries @Sciezgin @scilifelab and David Smith @FraunhoferIZI

[Nationale Akademie der Wissenschaften Leopoldina @Leopoldina]

Heute wurde der Medizinerin Bahriye Aktas sowie den Biophysikern @JochenGuck und Josef Käs der #GrevePreis der Leopoldina für ihre grundlegenden Erkenntnisse zur Beweglichkeit von #Tumorzellen verliehen. Die Auszeichnung ist mit 250.000 Euro dotiert: https://t.co/UD4PBTnGvY @maxplanckpress

[rivercyte @rivercyte]

Jochen has studied the physics of cancer cells using a variety of techniques, #DeformabilityCytometry among them. Check out our article for more details: https://t.co/isHtcbZP2c

[rivercyte @rivercyte]

We are super proud that one of @rivercyte co-founders @JochenGuck received the @Leopoldina Greve Prize for his cancer physics research. Congratulations 💫

[Max Planck Institute for the Science of Light @MPI_Light]

Understanding the physics of cancer, preventing metastases: Jochen Guck (@GuckLab) receives the @Leopoldina Greve Prize 👏

The ability to explain the conditions that lead to cancer metastases is key to developing new approaches to cancer treatment.

👉 https://t.co/NjZvGo0oV7

[rivercyte @rivercyte]

@MPI_Light @GuckLab @Leopoldina Congratulations @GuckLab !

[rivercyte @rivercyte]

The last 2 weeks we were busy with installations of Naiad hashtag#DeformabilityCytometry systems 👨‍🔧 👩‍🔬 🔬

⏩ One Naiad now lives @karolinskainst in Sweden and another found a home at @FraunhoferIZI in Germany.

You can test the Naiad, too - contact us!

[rivercyte @rivercyte]

📦✈️ Exciting day today - our Naiad #DeformabilityCytometer is flying out to Singapore! 🇸🇬 Did you know that you can rent the Naiad for a few months? ➡️ contact us at @rivercyte

[GuckLab 🇺🇦 @GuckLab]

Excited to share our latest paper in Nat Biomed Eng. With a #TissueGrinder we can dissociate biopsies and then use #RTDC and #AI to distinguish cancer from healthy tissue based on cell deformability and other physical parameters @MPZ_PhysMed @UniFAU
https://t.co/z7FAy3ZeNQ

[rivercyte @rivercyte]

Some days we brought our Naiad deformability cytometer to @SchubertLab at @UniCologne - it was awesome to test our device on completely new samples. Looking forward to future experiments! 🔬

[rivercyte @rivercyte]

📢 We are looking for a new colleague to help us with hardware design and development 🔬 Please spread the word!
https://t.co/8rbwQHTn5G

[rivercyte @rivercyte]

@ResearchGermany #startupjobs #erlangen

[rivercyte @rivercyte]

📢 We are looking for a new colleague to help us with hardware design and development 🔬 Please spread the word!
https://t.co/8rbwQHTn5G

[Markéta Kubánková @marke_kub]

@GuckLab for the opportunities, and @rivercyte co-founders who have been working so hard on shaping the startup, paving the way for future medical devices. Thank you🙏

https://t.co/tFDmrmUapK

[rivercyte @rivercyte]

Yesterday our founders @ShadaHattum and @KraterMartin presented our solutions in Regensburg at MedtechSUMMIT 2024, focused on the topic of AI in the field of diagnostics. We are super grateful for the fruitful discussions!

[Martin Kräter @KraterMartin]

#UniteToFight2024 is so needed for patients, for doctors, and for researchers. What an amazing effort! Thanks, Marco, Diana, and all the team for spending uncountable and, of course, unpaid hours to make it happen.

[rivercyte @rivercyte]

Day 3 at #EESMechanobiology Mechanics of Life conference @embl Heidelberg.

Last chance to visit @rivercyte (deformability cytometry) and @FFXcoveries (tissue grinder)!

Come to chat with us at our booth in the foyer :-)